While presenting the Frost and Sullivan Prize for Product Leadership to Kampala Pharmaceutical Industries (1996) Ltd yesterday, Dr Amandua explained that move is aimed at creating a level playing field for local manufacturers to compete fairly against importers.
Frost and Sullivan, a global research organization that monitors more than 300 industries and 250,000 companies worldwide carried out a survey in 2010 and recognized KPI’s performance for outstanding innovation product portfolio.
KPI, a subsidiary of the Aga Khan Development Network (AKDN) also outcompeted other players on product quality, innovative element, acceptance in the market place and customer value enhancements.
He said: “KPI was awarded for its willingness to invest in products that while not being necessarily profitable in the short term are increasingly needed by the Uganda population.”
Mr Nazeem Mohamed, the Chief Executive Officer of KPI said the award was an indicator of great achievement by the company despite the many challenges faced by local manufacturers which include high utility costs and unfair competition from dumping of cheap imports in the country.
“We are proud of this prize and we really worked for it being the first company to produce to Formin- a product that control 2 diabetes and Cardiac (amlodipine) that control high blood pressure in Uganda,” he said.